Hunan Chinasun Pharmaceutical Machinery Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 100.61 million compared to CNY 97.3 million a year ago. Revenue was CNY 100.61 million compared to CNY 97.3 million a year ago.

Net loss was CNY 323.65 million compared to CNY 192.74 million a year ago. Basic loss per share from continuing operations was CNY 0.9 compared to CNY 0.53 a year ago. Diluted loss per share from continuing operations was CNY 0.9 compared to CNY 0.53 a year ago.